Dr. Kevin Jones reports
MEDMIRA RECEIVES APPROVAL TO MARKET REVEALATRADEMARK RAPID HIV TEST WITH NEW FEATURES IN EUROPE
MedMira Inc. has received approval to market an enriched version of its Reveal HIV test that simplifies the test procedure, enabling direct use of whole
blood specimens -- making the test even more convenient for
point-of-care test users, especially in emergency situations when every
second counts. The new enhancements build on what is already the
fastest HIV test among all patented rapid diagnostic technologies
available in Europe.
According to the European Centre for Disease Prevention and Control-
and WHO/Europe-sponsored HIV/AIDS Surveillance in Europe 2012
report, HIV infection rates in Europe have increased 8 per cent
since 2011. The report calls for the need to make HIV testing more
available across Europe and for more accelerated action against HIV,
which at this time is often undiagnosed or diagnosed late in the course
of the disease. Terrence Higgins Trust, a United Kingdom HIV and sexual health
charity, released a report earlier this year, titled 2020 Vision: Making England's HIV Prevention Response the Best in the
World, urging government to increase testing initiatives by 250,000 tests per
year to drive down infection rates and undiagnosed HIV cases.
The Reveal HIV test can help meet this goal. This latest version of the
test includes a redesigned cartridge and InstantGold currency cap that changes
the whole blood procedure. Now users can pour the sample directly into
the cartridge, enabling greater ease of use and faster results. By
increasing throughput with instant results, users can also achieve
greater cost-efficiencies.
"With infection rates on the rise across Europe, the need for rapid
testing has never been more apparent," said Dr. Kevin Jones, PhD, senior
director, global sales and marketing, MedMira. "Our improved whole
blood procedure will enable users to test for HIV even more quickly,
which is critical in point-of-care situations. We make advancements to
our rapid-vertical-flow technology based on customer feedback and needs,
as well as industry trends. This latest version optimizes the user
experience, and our redesigned cartridge and cap will be used in all of
MedMira's new products that are available through our current and
future sales channels."
The Reveal HIV test is an easy-to-use first line of defence against the
spread of HIV infection. Built on MedMira's patented rapid-vertical-flow technology, the three-step procedure does not require any specialized training or
equipment, and results are easy to interpret. The company's rapid HIV
test is also moving through the approval process with the United States Food and Drug Administration.
Both the European Union and U.S. tests include the same features and benefits --
three easy steps from go to know -- and add a host of features that
further simplify the procedure.
We seek Safe Harbor.
© 2024 Canjex Publishing Ltd. All rights reserved.